Lipocine News, Lipocine Quote, LPCN Quote

Lipocine (NQ:LPCN) Delayed: 1.60 -0.02 (1.23%)

Prev. Close

$1.62

Today 6M 1Y 5Y

Open

$1.59

52 Wk High

$14.80

52 Wk Low

$2.51

Day High

$1.64

Day Low

$1.58

P/E

N/A

EPS

$-0.69

Volume

159,968

Friends, Peers and Foes (?): ACET, APRE, CGC, DFTX, DOSEF (more...)

ALERTS | RSS

Oct 20, 2026 07:47 AM Form 8-K Lipocine Inc. For: Oct 20
Oct 7, 2026 08:56 AM Lipocine stock surges 30% on Health Canada drug approval
Oct 7, 2026 08:01 AM Health Canada approves Lipocine's oral testosterone drug TLANDO
Oct 7, 2026 08:00 AM Lipocine Announces Health Canada Approval of TLANDO® for Testosterone Replacement Therapy
Oct 7, 2026 06:13 AM Health Canada approves Tlando oral testosterone therapy from Lipocine
Oct 7, 2026 06:10 AM Form 8-K Lipocine Inc. For: Oct 07
Oct 1, 2026 08:28 PM Form 4 Lipocine Inc. For: Sep 29 Filed by: Higuchi John W.
Sep 30, 2026 08:39 PM Form 4 Lipocine Inc. For: Sep 28 Filed by: Higuchi John W.
Sep 22, 2026 07:35 AM H.C. Wainwright Reiterates Neutral Rating on Lipocine Inc (LPCN)
Sep 16, 2026 04:38 PM Form 8-K Lipocine Inc. For: Sep 16

Entities mentioned with LPCN

View All Entities